ClinicalTrials.Veeva

Menu

The Impact of Frailty on Thrombosis of Elderly Patients With NVAF (FTE-NVAF)

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

Non-valvular Atrial Fibrillation, Elderly, Frailty, Thrombosis

Treatments

Other: Diagnostic Test: CHA2DS2-VASc, HAS-BLED and Fried Scale.

Study type

Observational

Funder types

Other

Identifiers

NCT04476147
BFH - Frailty and thrombosis

Details and patient eligibility

About

This study aims to investigate the use of anticoagulants in elderly patients with non-valvular atrial fibrillation (NVAF) and the incidence of frailty in elderly patients with NVAF. After two years follow-up, we observe the incidence of thrombotic events and the influence of frailty on thrombotic events in elderly patients with NVAF.

Enrollment

500 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥65yr
  • Confirmed non-valvular atrial fibrillation (NVAF) diagnosis with ECG or Holter
  • fulfilled CHA2DS2-VASc, HAS-BLED and Fried Scale
  • patients agreed and provided informed consent

Exclusion criteria

  • valvular atrial fibrillation
  • cardiac surgery related atrial fibrillation
  • acute disease related atrial fibrillation
  • patients not fulfilled all the exam and text,or not accept the follow-up

Trial design

500 participants in 1 patient group

Participates
Description:
This is an observational study
Treatment:
Other: Diagnostic Test: CHA2DS2-VASc, HAS-BLED and Fried Scale.

Trial contacts and locations

1

Loading...

Central trial contact

Yunli Xing, Dr.; Hongwei Li, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems